Rheonix Wins $233K NIAID Grant to Add UTI Detection to Multiplex STD Molecular Dx
August 26, 2010
Rheonix Wins $233K NIAID Grant to Add UTI Detection to Multiplex STD Molecular Dx
The long-term goal of the project is to develop a single test for detecting an array of STDs and UTIs using Rheonix's fully automated point-of-care molecular diagnostic platform, called CARD.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.